Health Sciences Acquisitions 2 Profit Margin

Health Sciences Acquisitions 2 (HSAQ) currently reports a profit margin of -186.3% as of June 2026. That compares with -2817.24% in the prior-year period — up 93.4% year over year. That is below the sector sector average of 21.34%. Use the charts on this page to explore Health Sciences Acquisitions 2's profit margin history and peer comparisons.

Health Sciences Acquisitions 2's profit margin increased from -2817.24% to -186.3% — a 93.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Health Sciences Acquisitions 2's profit margin of -186.3% is lower than the its sector sector average of 21.34%. That is roughly 972.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Health Sciences Acquisitions 2's current -186.3% should be judged against industry norms (sector average: 21.34%) and against HSAQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -186.3%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 21.34%. From there, open related valuation or income-statement pages for Health Sciences Acquisitions 2, and consider following HSAQ for alerts when major investors trade the stock.